The NLRP3 inflammasome has emerged as a critical regulator in neuroinflammatory responses to various brain insults from traumatic, ischemic and neurodegenerative conditions, an effect almost exclusively attributed to microglial NLRP3. Here, we demonstrated that in the absence of changes in inflammatory factors IL-18, IL-1β and TNF-α, neuronal Nlrp3 knockout in hippocampus (nNlrp3 -/- ) improved long-term spatial memory performance, with increased synaptic proteins levels and enhanced amplitude of long-term potentiation at 4 weeks after traumatic brain injury (TBI), compared to wildtype littermates. Notably, the nNlrp3 -/- mice out-performed microglia-specific knockout and global Nlrp3 knockout mice in cognition and synaptic function. We further identified that NLRP3 structurally and functionally directly interacted with the R1 subunit of N-methyl-D-aspartate receptor (NR1) in hippocampus after TBI. Accordingly, pharmacological inhibition of NLRP3 by MCC950 rescued the decrease in the NMDAR-gated calcium influx by LPS-stimulated hippocampal neurons while selective Nlrp3 knockout in hippocampal neurons partially reversed the decreased phosphorylation level of NR1 after TBI. Collectively, this study provides the first evidence that neuronal NLRP3 constitutes a non-inflammatory response to control synaptic plasticity and cognitive function via NR1-dependent non-inflammatory mechanism in TBI and thus broadens the central role of NLRP3 in neuronal adaptive mechanisms to include both microglial NLRP3-inflammation arm and the neuronal NLRP3-synaptic plasticity arm.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: